Literature DB >> 20831537

Hepatotoxicity of alpha-methyldopa in pregnancy.

R Slim1, C Ben Salem, H Hmouda, K Bouraoui.   

Abstract

Alpha-methyldopa is one of the most widely prescribed antihypertensive agents used during pregnancy. Despite its known potential hepatotoxicity, there have been only a few reports describing hepatotoxicity with the use of this drug during pregnancy. We report here a new case of acute hepatitis in a pregnant woman related to the use of alpha-methyldopa, and briefly review the literature on alpha-methyldopa-induced hepatotoxicity in pregnancy.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20831537     DOI： 10.1111/j.1365-2710.2009.01078.x

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN： 0269-4727            Impact factor:   2.512


  3 in total

1.  α-Methyldopa-induced hepatitis during the postpartum period.

Authors:  Soleiman Kashkooli; Brandon Baraty; Jamshid Kalantar
Journal:  BMJ Case Rep       Date:  2014-02-27

2.  Drug-induced fulminant hepatic failure in pregnancy.

Authors:  Tabassum Firoz; Douglas Webber; Hilary Rowe
Journal:  Obstet Med       Date:  2015-09-15

3.  Medication Use among Pregnant Women from the 2015 Pelotas (Brazil) Birth Cohort Study.

Authors:  Bárbara Heather Lutz; Vanessa Iribarrem Avena Miranda; Marysabel Pinto Telis Silveira; Tatiane da Silva Dal Pizzol; Sotero Serrate Mengue; Mariângela Freitas da Silveira; Marlos Rodrigues Domingues; Andréa Dâmaso Bertoldi
Journal:  Int J Environ Res Public Health       Date:  2020-02-05       Impact factor: 4.614
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.